Chemical | 07 June 2021
Bayer acquires Noria and PSMA Therapeutics
Broadens company’s oncology platform of Targeted Alpha Therapies (TATs)
Broadens company’s oncology platform of Targeted Alpha Therapies (TATs)
Sardar Brand agri inputs will now be available on the AgroStar website and app
Dior Addict Lip Maximizer is the first luxury product featuring Cristal Renew to hit shelves
Technip Energies will market and license the integrated technologies of Agilyx
The new design is available in three options allowing for content flexibility to meet customer’s needs
The company is planning to expand its ethanol capacity to 600 klpd in 2022 as our aim is to deliver more than 100 million litres to this programme
Aerospace sealants, coatings and adhesives helped ULA provide protection for the Atlas V 541 rocket, which aided the Perseverance rover in reaching its final destination
Voyager's workflow automation and visibility solution will bring material savings, as identified by OMV S&T
With large scale consolidation expected both in the pharma and specialty chemicals market, the winners will be the ones who can scale up efficiently as well as effectively – working smarter, rather than simply working harder or adding more capacity by hiring additional employees.
For the first time the two companies intend to collaborate on initiatives that will establish themselves in the clean ammonia value chain
1233zd is part of the new generation of fluorospecialties with no or minimal emissive impact, aligned with Arkema’s sustainable development strategy to address the opportunities linked to global mega-trends
Miedreich will succeed Marc Grynberg as CEO of the Group in the 4th quarter of this year
The proposed transaction was announced on 11 March 2021
Ethanol has become one of the major priorities of 21st century India
The company reported total income of Rs.982.53 crores during the 12 months period ended March 31, 2021
The company posted net profit of Rs.444.56 crores for the 12 months period ended March 31, 2021
It reported total income of Rs.69.22 crores during the 12 months period ended March 31, 2021
Revenue for the year ended March 31, 2021 was Rs. 283.08 crore in FY21 as compared to Rs. 283.64 crore in FY20
The company is doubling its chemistry research capacity that should commission by Q2'FY22
The company ramp ups manufacturing capacity of ethyl acetate from 87,000 MT per annum to 100,000 MT per annum
Subscribe To Our Newsletter & Stay Updated
